Guidelines for the supply of sildenafil for erectile dysfunction
REMOTE HEALTH ATLAS – Section #: TITLE (SPACE TO RIGHT FLUSH GUIDELINES FOR THE SUPPLY OF MEDICINES FOR ERECTILE DYSFUNCTION Note: where sildenafil 20mg tablets (Revatio®) are prescribed for pulmonary hypertension please refer to thregarding use under the Highly Specialised Drugs program.
Medicines (including phosphodiesterase 5 inhibitors (sildenafil, tadalafil and vardenafil), alprostadil and papaverine) for erectile dysfunction are not funded under the PBS/ S100 arrangements. Sildenafil is available through Regional Hospital Pharmacies for the treatment of erectile dysfunction via theand the approval of the Regional Senior Rural Medical Practitioner (SRMP) - Operations (Ops). Where the client meets the criteria of these guidelines and is approved the SRMP - Ops the Remote Health Branch will meet the full cost.
Where a client does not meet the inclusion criteria, requires supply more frequently than endorsed within this guideline, or supply is not approved by the SRMP - Ops the Rural Medical Practitioner (RMP) may provide a private prescription and the client will need to make their own arrangements for supply, including delivery and payment, with a pharmacy of their choice. Pharmacies that have existing supply arrangements with Remote Health Centres are listed at the bottom of this guideline*.
A medicine for erectile dysfunction may be supplied, with full department funding, only where the client meets the following criteria:
paraplegia; or condition is secondary to diabetes; or other specific conditions which may be considered on a case by case basis.
Supply under departmental funding arrangements is subject to the prescription being:
written for a maximum of 4 tablets or 5 injections per supply event; and dispensed by the Regional Hospital Pharmacy with a minimum period of 6 months
The RMP should include information regarding the aetiology for the erectile dysfunction within the ‘Rationale / Justification’ section of the
It is the responsibility of the RMP to inform the client about the restrictions to supply of a medicine for erectile dysfunction when fully funded by RHB, and their options to obtain additional supplies where appropriate.
Initial approval for supply of a medicine for erectile dysfunction, will be for one supply event only, and an assessment of effectiveness must be conducted by the RMP within 6 months, to establish if treatment should be continued. Where continued additional review of effectiveness must be conducted at a minimum of every 12 months. *Pharmacies (include but are not limited to) Contact Details: Pharmacy
Developed by: Remote Health Pharmacy Group
Endorsed by: Remote Executive Leadership Group
Mobile applications and the mobile web represent a huge opportunity for developers. But there are challenges for web developers looking to access the $15bn app market. Trigger’s development framework, Forge, enables web developers for mobile by combining HTML5 technology ■ Rapid growth of smartphones, rapid growth of mobile appsSmartphones are now one of the most indispensable technologi
CLINICIAN’S CORNER Management of Fibromyalgia Syndrome Don L. Goldenberg, MD Context The optimal management of fibromyalgia syndrome (FMS) is unclear and comprehensive evidence-based guidelines have not been reported. Objective To provide up-to-date evidence-based guidelines for the optimal treat- ment of FMS. ATANYONETIME,10%TO12% DataSources,Selection,andExtraction Asearchofallhu